OpenURL Connection Search

Select item for more details and to access through your institution.

MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: No.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 21, doi. 10.1177/13524585231222140
By:
- Marignier, Romain;
- Cree, Bruce AC
Publication type:
Article
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Yes.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 19, doi. 10.1177/13524585231222132
By:
- Carnero Contentti, Edgar;
- Wingerchuk, Dean M
Publication type:
Article
The Finger Dexterity Test: Validation study of a smartphone-based manual dexterity assessment.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 121, doi. 10.1177/13524585231216007
By:
- Van Laethem, Delphine;
- Denissen, Stijn;
- Costers, Lars;
- Descamps, Annabel;
- Baijot, Johan;
- Van Remoortel, Ann;
- Van Merhaegen-Wieleman, Annick;
- D'hooghe, Marie B;
- D'Haeseleer, Miguel;
- Smeets, Dirk;
- Sima, Diana M;
- Van Schependom, Jeroen;
- Nagels, Guy
Publication type:
Article
A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 25, doi. 10.1177/13524585231214360
By:
- Daboul, Lynn;
- O'Donnell, Carly M;
- Amin, Moein;
- Rodrigues, Paulo;
- Derbyshire, John;
- Azevedo, Christina;
- Bar-Or, Amit;
- Caverzasi, Eduardo;
- Calabresi, Peter A;
- Cree, Bruce AC;
- Freeman, Leorah;
- Henry, Roland G;
- Longbrake, Erin E;
- Oh, Jiwon;
- Papinutto, Nico;
- Pelletier, Daniel;
- Prchkovska, Vesna;
- Raza, Praneeta;
- Ramos, Marc;
- Samudralwar, Rohini D
Publication type:
Article
Stretching is not essential for managing MS spasticity: A randomized controlled trial.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 89, doi. 10.1177/13524585231215960
By:
- Hugos, Cinda L;
- Joos, Sandra K;
- Perumean-Chaney, Suzanne E;
- Cutter, Gary R;
- Cameron, Michelle H
Publication type:
Article
The disease-modifying therapy utilisation and cost trend for multiple sclerosis in Australia between 2013 and 2022.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 80, doi. 10.1177/13524585231213230
By:
- Zhao, Ting;
- Taylor, Bruce V;
- Campbell, Julie A;
- Palmer, Andrew J
Publication type:
Article
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 103, doi. 10.1177/13524585231214362
By:
- Dalla Costa, Gloria;
- Nos, Carlos;
- Zabalza, Ana;
- Buron, Mathias;
- Magyari, Melinda;
- Sellebjerg, Finn;
- Guerrero, Ana Isabel;
- Roselli, Lucia;
- La Porta, Maria Libera;
- Martinis, Matteo;
- Bailon, Raquel;
- Kontaxis, Spyridon;
- Laporta, Estela;
- Garcia, Esther;
- Pokorny, Florian B;
- Schuller, Björn W;
- Folarin, Amos;
- Stewart, Callum;
- Leocani, Letizia;
- Vairavan, Srinivasan
Publication type:
Article
MRI of the relevant domain should be performed to confirm whether clinical symptoms represent an attack of NMOSD: Commentary.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 23, doi. 10.1177/13524585231222131
By:
- Weinshenker, Brian G
Publication type:
Article
Effectiveness of a blended booster programme for the long-term outcome of cognitive behavioural therapy for MS-related fatigue: A randomized controlled trial.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 71, doi. 10.1177/13524585231213258
By:
- de Gier, Marieke;
- Beckerman, Heleen;
- Twisk, Jos WR;
- Knoop, Hans;
- de Groot, Vincent
Publication type:
Article
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 63, doi. 10.1177/13524585231215268
By:
- Dobson, Ruth;
- Holden, David;
- Vickaryous, Nicola;
- Bestwick, Jonathan;
- George, Katila;
- Sayali, Tatiana;
- Bianchi, Lucia;
- Wafa, Mohammad;
- Gold, Julian;
- Giovannoni, Gavin
Publication type:
Article
Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 35, doi. 10.1177/13524585231213164
By:
- Ladakis, Dimitrios C;
- Reyes-Mantilla, Maria I;
- Gadani, Sachin P;
- Mace, Jackson W;
- Dominguez-Penuela, Susana C;
- Appiah, Mayaa J;
- Smith, Matthew D;
- Bhargava, Pavan;
- Fox, Robert J;
- Saidha, Shiv;
- Calabresi, Peter A
Publication type:
Article
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 44, doi. 10.1177/13524585231212879
By:
- Mattiesing, Rozemarijn M;
- Kramer, Eline;
- Strijbis, Eva MM;
- Brouwer, Iman;
- van Schijndel, Ronald A;
- Gentile, Giordano;
- Battaglini, Marco;
- De Stefano, Nicola;
- Uitdehaag, Bernard MJ;
- Barkhof, Frederik;
- Vrenken, Hugo;
- Schoonheim, Menno M
Publication type:
Article
Deciphering prognostic indicators in AQP4-IgG-seropositive neuromyelitis optica spectrum disorder: An integrative review of demographic and laboratory factors.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 7, doi. 10.1177/13524585231212832
By:
- Guo, Ruo-Yi;
- Wang, Wen-Ya;
- Huang, Jing-Ying;
- Jia, Zhen;
- Sun, Ya-Fei;
- Li, Bin
Publication type:
Article
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 131, doi. 10.1177/13524585231206218
By:
- Beigneux, Ysoline;
- Louapre, Celine;
- Bihan, Kevin;
- Roux, Thomas;
- de Paz, Raphael;
- Lubetzki, Catherine;
- Maillart, Elisabeth
Publication type:
Article
Managing patients with late-onset neutropenia during treatment with ocrelizumab.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 134, doi. 10.1177/13524585231206219
By:
- Wright, Sarah L;
- Thompson, Alan J
Publication type:
Article
Disease-modifying therapies enter the World Health Organization Essential Medicines List: A victory now requiring a roadmap of implementation.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 3, doi. 10.1177/13524585231205970
By:
- Yamout, Bassem I.;
- Viswanathan, Shanthi;
- Laurson-Doube, Joanna;
- Sokhi, Dilraj
Publication type:
Article
Re-thinking race and geography in multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 16, doi. 10.1177/13524585231205969
By:
- Ontaneda, Daniel;
- Amezcua, Lilyana
Publication type:
Article
Using instrumental variables to correct for bias in real-world cohort studies of the effects of disease-modifying treatment in MS.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 113, doi. 10.1177/13524585231201423
By:
- Koch-Henriksen, Nils Iørgen;
- Thygesen, Lau Caspar;
- Sørensen, Per Soelberg;
- Magyari, Melinda
Publication type:
Article
Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis.
Published in:
Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 55, doi. 10.1177/13524585231201093
By:
- Berek, Klaus;
- Hegen, Harald;
- Auer, Michael;
- Barket, Robert;
- Di Pauli, Franziska;
- Hocher, Jakob;
- Krajnc, Nik;
- Zinganell, Anne;
- Deisenhammer, Florian;
- Berger, Thomas;
- Bsteh, Gabriel
Publication type:
Article

Found: 19